ArticleBiomaterials2022

Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: A novel therapeutic solution to treat ulcerative colitis.

Junsik Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.